4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-047197
See Remarks sold 150,000 shares at $2.80 ($420,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KINGSLEY ALFRED D See Remarks | 2017-07-31 | Sale | −150,000 | $2.80 | $420,000 | 5,781,555 | D |
| Open-market sales · 150,000 sh · avg $2.80 · $420,000 | |||||||
Loading xslF345X03/doc4.xml…